This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Fundamental changes to the GP contract regarding vaccinations and immunisations as of April 2021

ZOSTAVAX® (shingles (herpes zoster) vaccine live)
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

M-M-RVAXPRO® (measles, mumps and rubella vaccine (live))
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

ZOSTAVAX® (shingles (herpes zoster) vaccine live)
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

M-M-RVAXPRO® (measles, mumps and rubella vaccine (live))
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

Length: 16:09

Video objectives:

  • To provide an update on the detail of the updated vaccination and immunisation domains in QOF
  • An update on the changes to the shingles national immunisation programme (NIP)
  • How to optimise these QOF measures in your practice

More information about ZOSTAVAX® (shingles (herpes zoster) vaccine live):

Supporting documentation

ZOSTAVAX® (shingles (herpes zoster) vaccine live)
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)

M-M-RVAXPRO® (measles, mumps and rubella vaccine (live))
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)

By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website

GB-CIN-00359 | Date of Preparation: April 2022